Search Results - "GUÉCHOT, J."

Refine Results
  1. 1

    Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C by Fartoux, L, Poujol-Robert, A, Guéchot, J, Wendum, D, Poupon, R, Serfaty, L

    Published in Gut (01-07-2005)
    “…Background: Insulin resistance is a frequent feature of chronic hepatitis C. Whether insulin resistance could be the cause or consequence of steatosis and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis by Guéchot, J, Laudat, A, Loria, A, Serfaty, L, Poupon, R, Giboudeau, J

    Published in Clinical chemistry (Baltimore, Md.) (01-04-1996)
    “…Diagnostic accuracy of two serum markers of liver fibrosis, hyaluronan (HA) and amino-terminal peptide of type III procollagen (P-III-P), was studied in a…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis by GUECHOT, J, SERFATY, L, BONNAND, A.-M, CHAZOUILLERES, O, POUPON, R. E, POUPON, R

    Published in Journal of hepatology (01-03-2000)
    “…Serum hyaluronan (HA) levels increase according to the degree of liver fibrosis in patients with chronic viral hepatitis C. Patients with liver disease and…”
    Get full text
    Journal Article
  9. 9

    Apports de la LC-MS/MS pour le diagnostic et le suivi des hyperplasies congénitales des surrénales by Lamazière, A, Guéchot, J, Helin, N, Le Bouc, Y, Fiet, J

    Published in Annales d'endocrinologie (01-09-2016)
    “…Objectifs Développer un profil stéroïdien quantitatif par spectrométrie de masse pour l’étude des déficits enzymatiques surrénaliens (DES) et ainsi substituer…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration by POPOT, M.-A., BONNAIRE, Y., GUÉCHOT, J., TOUTAIN, P.-L.

    Published in Equine veterinary journal (01-09-2004)
    “…Summary Reasons for performing study: Hyaluronic acid (HA) is an endogenous glycosaminoglycan used in the treatment of joint diseases, but medication control…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery by Barbault-Foucher, S, Gref, R, Russo, P, Guechot, J, Bochot, A

    Published in Journal of controlled release (30-10-2002)
    “…This study was performed to design a new ocular drug delivery system based on poly-ε-caprolactone (PCL) biodegradable nanospheres (NS) coated with a…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Thyroid function at the third trimester of pregnancy in a Northern French population by Bourcigaux, N, Lepoutre-Lussey, C, Guéchot, J, Donadille, B, Faugeron, I, Ouzounian, S, Christin-Maître, S, Bouchard, P, Duron, F

    Published in Annales d'endocrinologie (01-12-2010)
    “…Résumé But/objectif Pendant la grossesse, la synthèse des hormones thyroïdiennes augmente quand la prise d’iode est suffisante. L’interprétation du dosage…”
    Get full text
    Journal Article
  20. 20

    Enzyme calibrators: principle and practical use by Lessinger, J M, Schiele, F, Vialle, A, Férard, G, Myara, A, Guéchot, J, Imbert-Bismut, F, Lasnier, E, Piton, A, Voitot, H

    Published in Annales de biologie clinique (Paris) (01-05-2002)
    “…Results of catalytic activities of enzymes are highly dependent on the measurement procedures and on local conditions. Thus, only poorly marked improvement of…”
    Get more information
    Journal Article